Literature DB >> 25487881

Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.

Fatma Nabli1, Samia Ben Sassi, Rim Amouri, John E Duda, Matthew J Farrer, Fayçal Hentati.   

Abstract

Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) were found to be a significant cause of late-onset autosomal dominant forms of Parkinson's disease (PD). To determine the motor characteristics of LRRK2-related disease, we conducted a longitudinal study of 58 G2019S LRRK2-associated PD patients and compared them with genetically undefined (GU) PD patients. Fifty-eight patients diagnosed with PD-related LRRK2 G2019S mutation were included in the study and compared with 54 sporadic PD patients with negative tests for LRRK2 G2019S, PINK1, SNCA, PRKN, and DJ1 mutations. Patients were assessed at baseline and after a follow-up period of 6 years. The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), the Hoehn and Yahr, and the Schwab and England scores were determined. Logistic regression was used to examine associations of G2019S mutation status with motor phenotype and rate of motor decline. The LRRK2-associated PD patients had a mean age of onset of 56.25 ± 12.05 years and in most cases (58.6%) a postural instability gait difficulty (PIGD) phenotype. The mean annual decline in the MDS-UDRS III motor score and the Hoehn and Yahr staging was of 1.3% and 2%, respectively. The PIGD phenotype predicted a more rapid progression of motor impairment. The PD motor phenotype and motor scores were similar in the LRRK2-associated PD group and in the GU PD group, with no significant differences in the progression rate of motor impairment. Motor phenotype seems to be similar in LRRK2-related PD and idiopathic PD.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  G2019S mutation; LRRK2 gene; PARK8; Parkinson's disease; longitudinal study

Mesh:

Substances:

Year:  2014        PMID: 25487881     DOI: 10.1002/mds.26097

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.

Authors:  Wei-Xi Xiong; Yi-Min Sun; Rong-Yuan Guan; Su-Shan Luo; Chen Chen; Yu An; Jian Wang; Jian-Jun Wu
Journal:  J Neurol       Date:  2016-07-08       Impact factor: 4.849

Review 2.  LRRK2 in Parkinson disease: challenges of clinical trials.

Authors:  Eduardo Tolosa; Miquel Vila; Christine Klein; Olivier Rascol
Journal:  Nat Rev Neurol       Date:  2020-01-24       Impact factor: 42.937

3.  Progression in the LRRK2-Asssociated Parkinson Disease Population.

Authors:  Rachel Saunders-Pullman; Anat Mirelman; Roy N Alcalay; Cuiling Wang; Roberto A Ortega; Deborah Raymond; Helen Mejia-Santana; Martha Orbe-Reilly; Brooke A Johannes; Avner Thaler; Laurie Ozelius; Avi Orr-Urtreger; Karen S Marder; Nir Giladi; Susan B Bressman
Journal:  JAMA Neurol       Date:  2018-03-01       Impact factor: 18.302

4.  Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease.

Authors:  Xiao Deng; Bin Xiao; Hui-Hua Li; Yew-Long Lo; Lai-Mun Chew; Kumar M Prakash; Eng-King Tan
Journal:  J Neurol       Date:  2015-07-26       Impact factor: 4.849

5.  Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease.

Authors:  Marta San Luciano; Cuiling Wang; Roberto A Ortega; Nir Giladi; Karen Marder; Susan Bressman; Rachel Saunders-Pullman
Journal:  Ann Clin Transl Neurol       Date:  2017-10-19       Impact factor: 4.511

6.  Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Li Shu; Yuan Zhang; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

Review 7.  Postural Instability in Parkinson's Disease: A Review.

Authors:  Bhavana Palakurthi; Sindhu Preetham Burugupally
Journal:  Brain Sci       Date:  2019-09-18

Review 8.  Profiling Non-motor Symptoms in Monogenic Parkinson's Disease.

Authors:  Xinyao Liu; Weidong Le
Journal:  Front Aging Neurosci       Date:  2020-10-30       Impact factor: 5.750

Review 9.  Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.

Authors:  Seung Hyun Lee; Sang-Min Park; Sang Seok Yeo; Ojin Kwon; Mi-Kyung Lee; Horyong Yoo; Eun Kyoung Ahn; Jae Young Jang; Jung-Hee Jang
Journal:  Diagnostics (Basel)       Date:  2022-01-04

Review 10.  LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.

Authors:  Shirley Yin-Yu Pang; Rachel Cheuk Nam Lo; Philip Wing-Lok Ho; Hui-Fang Liu; Eunice Eun Seo Chang; Chi-Ting Leung; Yasine Malki; Zoe Yuen-Kiu Choi; Wing Yan Wong; Michelle Hiu-Wai Kung; David Boyer Ramsden; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2022-01-31       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.